Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06015022
PHASE2

EGCG for Hepatocellular Carcinoma Chemoprevention

Sponsor: University of Texas Southwestern Medical Center

View on ClinicalTrials.gov

Summary

This phase II trial tests epigallocatechin gallate (EGCG) for its efficacy and safety in preventing development of hepatocellular carcinoma (HCC) in patients with liver cirrhosis.

Official title: Phase II Randomized Controlled Trial of Epigallocatechin Gallate for Hepatocellular Carcinoma Chemoprevention

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2024-09-01

Completion Date

2028-08-31

Last Updated

2025-09-05

Healthy Volunteers

No

Interventions

DRUG

Epigallocatechin gallate (EGCG)

EGCG is a green tea-derived catechin

OTHER

Placebo

Placebo in the same capsule with the experimental agent (EGCG).

Locations (1)

UT Southwestern

Dallas, Texas, United States